Literature DB >> 28160953

Interpreting Laboratory Tests in Infection: Making Sense of Biomarkers in Sepsis and Systemic Inflammatory Response Syndrome for Intensive Care Unit Patients.

Jennifer B Martin1, Jennifer E Badeaux2.   

Abstract

Sepsis and severe sepsis are leading causes of death in the United States and the most common causes of death among critically ill patients in noncoronary intensive care units. Diagnosis of infection and sepsis is a subjective clinical judgment based on the criteria for systemic inflammatory reaction, which is highly sensitive, not specific, and often misleading in intensively treated patients. Biomarkers are emerging as adjuncts to traditional diagnostic measures. No biomarkers have sufficient specificity or sensitivity to be routinely used in clinical practice, but they can aid in the diagnosis and treatment of infection versus inflammation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Infection; Inflammation; Intensive care; SIRS; Sepsis

Mesh:

Substances:

Year:  2016        PMID: 28160953     DOI: 10.1016/j.cnc.2016.09.004

Source DB:  PubMed          Journal:  Crit Care Nurs Clin North Am        ISSN: 0899-5885            Impact factor:   1.326


  5 in total

1.  MicroRNA-365 regulates the occurrence and immune response of sepsis following multiple trauma via interleukin-6.

Authors:  Hui Gong; Xiaomin Sheng; Jianhua Xue; Dongbo Zhu
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

2.  Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study.

Authors:  Eduarda Cristina Martins; Lilian da Fe Silveira; Karin Viegas; Andrea Diez Beck; Geferson Fioravantti Júnior; Rafael Viegas Cremonese; Priscila Schmidt Lora
Journal:  Rev Bras Ter Intensiva       Date:  2019-03-21

3.  Does Neutrophil-to-lymphocyte Ratio at Admission Predict Severity and Mortality in COVID-19 Patients? A Systematic Review and Meta-analysis.

Authors:  Prattay Guha Sarkar; Pragya Pant; Jagmohan Kumar; Amit Kumar
Journal:  Indian J Crit Care Med       Date:  2022-03

4.  Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing.

Authors:  David W Eyre; Warren N Fawley; Anu Rajgopal; Christopher Settle; Kalani Mortimer; Simon D Goldenberg; Susan Dawson; Derrick W Crook; Tim E A Peto; A Sarah Walker; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2017-08-01       Impact factor: 9.079

5.  Paeonol attenuates inflammation by targeting HMGB1 through upregulating miR-339-5p.

Authors:  Liyan Mei; Meihong He; Chaoying Zhang; Jifei Miao; Quan Wen; Xia Liu; Qin Xu; Sen Ye; Peng Ye; Huina Huang; Junli Lin; Xiaojing Zhou; Kai Zhao; Dongfeng Chen; Jianhong Zhou; Chun Li; Hui Li
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.